Hu_2003_J.Neurochem_86_470

Reference

Title : Amyloid-beta increases acetylcholinesterase expression in neuroblastoma cells by reducing enzyme degradation - Hu_2003_J.Neurochem_86_470
Author(s) : Hu W , Gray NW , Brimijoin S
Ref : Journal of Neurochemistry , 86 :470 , 2003
Abstract :

Amyloid-beta (Abeta) is the principal protein constituent of 'senile plaques' and is a suspected mediator in Alzheimer's disease (AD). Senile plaques also contain acetylcholinesterase (AChE; EC 3.1.1.7), which may have a role in promoting Alphabeta-toxicity. We have found that Alphabeta can affect AChE expression in a neuron-like line, the N1E.115 neuroblastoma cell. When 1 micro mAlphabeta 1-42 or 25-35 was added for 24 h to differentiating N1E.115 in culture, AChE activity increased 30-40% in adherent cells, and 100% or more in nonadherent cells. The changes in both tetrameric (G4) and monomeric (G1) AChE forms were comparable. Turnover studies indicated that the elevation of AChE activity reflected slowed AChE degradation rather than accelerated synthesis. With a similar time course, Alphabeta also increased the quantity of muscarinic receptors on the plasma membrane. Immunocytochemistry for a lysosomal membrane protein (LAMP-1) indicated no change in abundance or localization of lysosomes in treated cells. But decreased labeling by pH-sensitive fluorescent dye pointed to an impairment of lysosomal acidification. We consider that the alteration of AChE expression after Alphabeta-exposure could reflect lysosomal dysfunction, and might itself enhance Alphabeta-toxicity.

PubMedSearch : Hu_2003_J.Neurochem_86_470
PubMedID: 12871588

Related information

Citations formats

Hu W, Gray NW, Brimijoin S (2003)
Amyloid-beta increases acetylcholinesterase expression in neuroblastoma cells by reducing enzyme degradation
Journal of Neurochemistry 86 :470

Hu W, Gray NW, Brimijoin S (2003)
Journal of Neurochemistry 86 :470